Clinical Trial Update: Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab combined with cisplatin for advanced cutaneous squamous cell carcinoma is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Squamous Cell Carcinoma of the Skin | Phase 2 | Status: UNKNOWN